Delcath Systems, Inc. (DCTH) vs Pacific Biosciences of California, Inc. (PACB)
- Delcath Systems, Inc. DCTH 14.08 −4.93%
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
Delcath Systems, Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $609.2M against $513.9M — 1.2× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Delcath Systems, Inc. trades at 1,408×. Delcath Systems, Inc. grew revenue faster over the last twelve months: 35.9% against 2.02%. Delcath Systems, Inc. has the higher net margin (0.56% vs −82.5%) and the higher return on invested capital (−4.49% vs −22.2%). Across the 17 metrics below, Delcath Systems, Inc. leads on 14 and Pacific Biosciences of California, Inc. on 3.
Valuation
Profitability
| Metric | DCTH | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 87.05% | 36.38% | 56.01% |
| Operating margin | (1.90%) | (83.53%) | (15.03%) |
| Net margin | 0.56% | (82.49%) | (20.40%) |
| Free cash flow margin | 18.35% | (50.53%) | (7.24%) |
| Return on equity | 0.47% | (929.31%) | (15.32%) |
| Return on assets | 0.42% | (16.66%) | (19.72%) |
| Return on invested capital | (4.49%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack